Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' BENET LZ' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 139 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Grillo, MP; Benet, LZ
      Interaction of gamma-glutamyltranspeptidase with clofibryl-S-acyl-glutathione in vitro and in vivo in rat

      CHEMICAL RESEARCH IN TOXICOLOGY
    2. Cummins, CL; Mangravite, LM; Benet, LZ
      Characterizing the expression of CYP3A4 and efflux transporters (P-gp, MRP1, and MRP2) in CYP3A4-transfected Caco-2 cells after induction with sodiumbutyrate and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate

      PHARMACEUTICAL RESEARCH
    3. Parasrampuria, DA; Lantz, MV; Benet, LZ
      A human lymphocyte based ex vivo assay to study the effect of drugs on P-glycoprotein (P-gp) function

      PHARMACEUTICAL RESEARCH
    4. Zhang, YC; Benet, LZ
      The gut as a barrier to drug absorption - Combined role of cytochrome P4503A and P-glycoprotein

      CLINICAL PHARMACOKINETICS
    5. Benet, LZ; Cummins, CL
      The drug efflux-metabolism alliance: biochemical aspects

      ADVANCED DRUG DELIVERY REVIEWS
    6. Wacher, VJ; Salphati, L; Benet, LZ
      Active secretion and enterocytic drug metabolism barriers to drug absorption

      ADVANCED DRUG DELIVERY REVIEWS
    7. Grillo, MP; Chiellini, G; Tonelli, M; Benet, LZ
      Effect of alpha-fluorination of valproic acid on valproyl-S-acyl-CoA formation in vivo in rats

      DRUG METABOLISM AND DISPOSITION
    8. Jacobsen, W; Serkova, N; Hausen, B; Morris, RE; Benet, LZ; Christians, U
      Comparison of the in vitro metabolism of the macrolide immunosuppressants sirolimus and RAD

      TRANSPLANTATION PROCEEDINGS
    9. Kuhn, B; Jacobsen, W; Christians, U; Benet, LZ; Kollman, PA
      Metabolism of sirolimus and its derivative everolimus by cytochrome P450 3A4: Insights from docking, molecular dynamics, and quantum chemical calculations

      JOURNAL OF MEDICINAL CHEMISTRY
    10. Tsunoda, SM; Harris, RZ; Christians, U; Velez, RL; Freeman, RB; Benet, LZ; Warshaw, A
      Red wine decreases cyclosporine bioavailability

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    11. Mancinelli, LM; Frassetto, L; Floren, LC; Dressler, D; Carrier, S; Bekersky, I; Benet, LZ; Christians, U
      The pharmacokinetics and metabolic disposition of tacrolimus: A comparisonacross ethnic groups

      CLINICAL PHARMACOLOGY & THERAPEUTICS
    12. Serkova, N; Jacobsen, W; Niemann, CU; Litt, L; Benet, LZ; Leibfritz, D; Christians, U
      Sirolimus, but not the structurally related RAD (everolimus), enhances thenegative effects of cyclosporine on mitochondrial metabolism in the rat brain

      BRITISH JOURNAL OF PHARMACOLOGY
    13. Christians, U; Jacobsen, W; Serkova, N; Benet, LZ; Vidal, C; Sewing, KF; Manns, MP; Kirchner, GI
      Automated, fast and sensitive quantification of drugs in blood by liquid chromatography-mass spectrometry with on-line extraction: immunosuppressants

      JOURNAL OF CHROMATOGRAPHY B
    14. Benet, LZ
      Permeability, metabolism, transporters and systemic exposure

      EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
    15. Boni, JP; Korth-Bradley, JM; Richards, LS; Chiang, ST; Hicks, DR; Benet, LZ
      Chiral bioequivalence - Effect of absorption rate on racemic etodolac

      CLINICAL PHARMACOKINETICS
    16. Christians, U; First, MR; Benet, LZ
      Recommendations for bioequivalence testing of cyclosporine generics revisited

      THERAPEUTIC DRUG MONITORING
    17. Jacobsen, W; Christians, U; Benet, LZ
      In vitro evaluation of the disposition of a novel cysteine protease inhibitor

      DRUG METABOLISM AND DISPOSITION
    18. Jacobsen, W; Kuhn, B; Soldner, A; Kirchner, G; Sewing, KF; Kollman, PA; Benet, LZ; Christians, U
      Lactonization is the critical first step in the disposition of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatin

      DRUG METABOLISM AND DISPOSITION
    19. Hausen, B; Ikonen, T; Briffa, N; Berry, GJ; Christians, U; Robbins, RC; Hook, L; Serkova, N; Benet, LZ; Schuler, W; Morris, RE
      Combined immunosuppression with cyclosporine (Neoral) and SDZ RAD in non-human primate lung transplantation: Systematic pharmacokinetic-based trials to improve efficacy and tolerability

      TRANSPLANTATION
    20. Serkova, N; Hausen, B; Berry, GJ; Jacobsen, W; Benet, LZ; Morris, RE; Christians, U
      Tissue distribution and clinical monitoring of the novel macrolide immunosuppressant SDZ-RAD and its metabolites in monkey lung transplant recipients: Interaction with cyclosporine

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    21. Soldner, A; Benet, LZ; Mutschler, E; Christians, U
      Active transport of the angiotensin-II antagonist losartan and its main metabolite EXP 3174 across MDCK-MDR1 and Caco-2 cell monolayers

      BRITISH JOURNAL OF PHARMACOLOGY
    22. Serkova, N; Litt, L; Leibfritz, D; Hausen, B; Morris, RE; James, TL; Benet, LZ; Christians, U
      The novel immunosuppressant SDZ-RAD protects rat brain slices from cyclosporine-induced reduction of high-energy phosphates

      BRITISH JOURNAL OF PHARMACOLOGY
    23. Soldner, A; Christians, U; Susanto, M; Wacher, VJ; Silverman, JA; Benet, LZ
      Grapefruit juice activates P-glycoprotein-mediated drug transport

      PHARMACEUTICAL RESEARCH
    24. Flanagan, SD; Benet, LZ
      Net secretion of furosemide is subject to indomethacin inhibition, as observed in Caco-2 monolayers and excised rat jejunum

      PHARMACEUTICAL RESEARCH
    25. Mizuma, T; McDonagh, AF; Lin, ET; Benet, LZ
      Photoinduced covalent binding of frusemide and frusemide glucuronide to human serum albumin

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    26. Benet, LZ; Izumi, T; Zhang, YC; Silverman, JA; Wacher, VJ
      Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery

      JOURNAL OF CONTROLLED RELEASE
    27. Mizuma, T; Benet, LZ; Lin, ET
      Interaction of human serum albumin with furosemide glucuronide: a role of albumin in isomerization, hydrolysis, reversible binding and irreversible binding of a 1-O-acyl glucuronide metabolite

      BIOPHARMACEUTICS & DRUG DISPOSITION
    28. Jacobsen, W; Kirchner, G; Hallensleben, K; Mancinelli, L; Deters, M; Hackbarth, I; Benet, LZ; Sewing, KF; Christians, U
      Comparison of cytochrome P-450-dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liver

      DRUG METABOLISM AND DISPOSITION
    29. Jager, W; Correia, MA; Bornheim, LM; Mahnke, A; Hanstein, WG; Xue, LL; Benet, LZ
      Ethynylestradiol-mediated induction of hepatic CYP3A9 in female rats: Implication for cyclosporine metabolism

      DRUG METABOLISM AND DISPOSITION
    30. Salphati, L; Benet, LZ
      Metabolism of digoxin and digoxigenin digitoxosides in rat liver microsomes: involvement of cytochrome P4503A

      XENOBIOTICA
    31. Benet, LZ; Bennett, WM
      Generic immunosuppressants - Introduction

      TRANSPLANTATION PROCEEDINGS
    32. Benet, LZ
      Understanding bioequivalence testing

      TRANSPLANTATION PROCEEDINGS
    33. Benet, LZ
      Relevance of pharmacokinetics in narrow therapeutic index drugs

      TRANSPLANTATION PROCEEDINGS
    34. Hausen, B; Boeke, K; Berry, GJ; Segarra, I; Benet, LZ; Christians, U; Morris, RE
      Coadministration of neoral and the novel rapamycin analog, SDZ RAD, to ratlung allograft recipients - Potentiation of immunosuppressive efficacy andimprovement of tolerability by staggered versus simultaneous treatment

      TRANSPLANTATION
    35. Zhang, YC; Guo, XS; Lin, ET; Benet, LZ
      In vitro biotransformation of a novel antimalarial cysteine protease inhibitor in human liver microsomes

      PHARMACOLOGY
    36. Jacobsen, W; Kirchner, G; Hallensleben, K; Mancinelli, L; Deters, M; Hackbarth, I; Baner, K; Benet, LZ; Sewing, KF; Christians, U
      Small intestinal metabolism of the 3-hydroxy-3-methylglutary-coenzyme A reductase inhibitor lovastatin and comparison with pravastatin

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    37. Serkova, N; Litt, L; James, TL; Sadee, W; Leibfritz, D; Benet, LZ; Christians, U
      Evaluation of individual and combined neurotoxicity of the immunosuppressants cyclosporine and sirolimus by in vitro multinuclear NMR spectroscopy

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    38. Segarra, I; Brazelton, TR; Guterman, N; Hausen, B; Jacobsen, W; Morris, RE; Benet, LZ; Christians, U
      Development of a high-performance liquid chromatographic electrospray massspectrometric assay for the specific and sensitive quantification of the novel immunosuppressive macrolide 40-O-(2-hydroxyethyl)rapamycin

      JOURNAL OF CHROMATOGRAPHY B
    39. MIZUMA T; BENET LZ; LIN ET
      HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION AND IDENTIFICATION OF ACYL MIGRATION AND PHOTODEGRADATION PRODUCTS OF FUROSEMIDE 1-O-ACYL GLUCURONIDE

      Journal of chromatography B. Biomedical sciences and applications
    40. MIZUMA T; BENET LZ; LIN ET
      PREPARATIVE CHROMATOGRAPHY OF FUROSEMIDE 1-O-ACYL-GLUCURONIDE FROM URINE USING MICRONIZED AMBERIITE XAD-2 AND ITS APPLICATION TO OTHER 1-O-ACYL-GLUCURONIDES

      Preparative biochemistry & biotechnology
    41. ZHANG YC; BENET LZ
      CHARACTERIZATION OF P-GLYCOPROTEIN MEDIATED TRANSPORT OF K02, A NOVELVINYLSULFONE PEPTIDOMIMETIC CYSTEINE PROTEASE INHIBITOR, ACROSS MDR1-MDCK AND CACO-2 CELL MONOLAYERS

      Pharmaceutical research
    42. Tsunoda, SM; Harris, RZ; Mroczkowski, PJ; Benet, LZ
      Preliminary evaluation of progestins as inducers of cytochrome P450 3A4 activity in postmenopausal women

      JOURNAL OF CLINICAL PHARMACOLOGY
    43. MOHRI K; OKADA K; BENET LZ
      STEREOSELECTIVE METABOLISM OF BENOXAPROFEN IN RATS - BILIARY-EXCRETION OF BENOXAPROFEN TAURINE CONJUGATE AND GLUCURONIDE

      Drug metabolism and disposition
    44. ZHANG YC; GUO XH; LIN ET; BENET LZ
      OVERLAPPING SUBSTRATE SPECIFICITIES OF CYTOCHROME-P450 3A AND P-GLYCOPROTEIN FOR A NOVEL CYSTEINE PROTEASE INHIBITOR

      Drug metabolism and disposition
    45. QIU Y; BURLINGAME AL; BENET LZ
      MECHANISMS FOR COVALENT BINDING OF BENOXAPROFEN GLUCURONIDE TO HUMAN SERUM-ALBUMIN - STUDIES BY TANDEM MASS-SPECTROMETRY

      Drug metabolism and disposition
    46. BENET LZ
      IMPACT OF INTRAINDIVIDUAL VARIABILITY OF DRUGS ON THERAPEUTIC OUTCOMES - LESSONS FROM OUTSIDE TRANSPLANTATION

      Transplantation proceedings
    47. SALPHATI L; BENET LZ
      EFFECTS OF KETOCONAZOLE ON DIGOXIN ABSORPTION AND DISPOSITION IN RAT

      Pharmacology
    48. JANG GR; BENET LZ
      ANTIPROGESTIN-MEDIATED INACTIVATION OF CYTOCHROME-P450 3A4

      Pharmacology
    49. LAMPEN A; ZHANG YC; HACKBARTH I; FLOREN LC; BENET LZ; SEWING KF; CHRISTIANS U
      METABOLISM AND TRANSPORT OF THE MACROLIDE IMMUNOSUPPRESSANT SIROLIMUSIN THE SMALL-INTESTINE

      Naunyn-Schmiedeberg's archives of pharmacology
    50. ZHANG YC; HSIEH YS; IZUMI T; LIN ET; BENET LZ
      EFFECTS OF KETOCONAZOLE ON THE INTESTINAL METABOLISM, TRANSPORT AND ORAL BIOAVAILABILITY OF K02, A NOVEL VINYLSULFONE PEPTIDOMIMETIC CYSTEINE PROTEASE INHIBITOR AND A P450 3A, P-GLYCOPROTEIN DUAL SUBSTRATE, INMALE SPRAGUE-DAWLEY RATS

      The Journal of pharmacology and experimental therapeutics
    51. LAMPEN A; ZHANG YC; HACKBARTH I; BENET LZ; SEWING KF; CHRISTIANS U
      METABOLISM AND TRANSPORT OF THE MACROLIDE IMMUNOSUPPRESSANT SIROLIMUSIN THE SMALL-INTESTINE

      The Journal of pharmacology and experimental therapeutics
    52. WACHER VJ; SILVERMAN JA; ZHANG YC; BENET LZ
      ROLE OF P-GLYCOPROTEIN AND CYTOCHROME-P450 3A IN LIMITING ORAL ABSORPTION OF PEPTIDES AND PEPTIDOMIMETICS

      Journal of pharmaceutical sciences
    53. QIU YC; BENET LZ; BURLINGAME AL
      IDENTIFICATION OF THE HEPATIC PROTEIN TARGETS OF REACTIVE METABOLITESOF ACETAMINOPHEN IN-VIVO IN MICE USING 2-DIMENSIONAL GEL-ELECTROPHORESIS AND MASS-SPECTROMETRY

      The Journal of biological chemistry
    54. SALPHATI L; BENET LZ
      MODULATION OF P-GLYCOPROTEIN EXPRESSION BY CYTOCHROME-P450 3A INDUCERS IN MALE AND FEMALE RAT LIVERS

      Biochemical pharmacology
    55. WU ST; CHANG YP; GEE WL; BENET LZ; LIN ET
      STEREOSELECTIVE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY DETERMINATION OF PROPRANOLOL AND 4-HYDROXYPROPRANOLOL IN HUMAN PLASMA AFTER PRECOLUMN DERIVATIZATION

      Journal of chromatography B. Biomedical sciences and applications
    56. WU ST; BENET LZ; LIN ET
      DETERMINATION OF AMIPRILOSE IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUOROMETRIC DETECTION

      Journal of chromatography B. Biomedical sciences and applications
    57. JANG GR; BENET LZ
      CYTOCHROME P4503A4-MEDIATIED N-DEMETHYLATION OF THE ANTIPROGESTINS LILOPRISTONE AND ONAPRISTONE

      Drug metabolism and disposition
    58. JANG GR; BENET LZ
      ANTIPROGESTIN PHARMACODYNAMICS, PHARMACOKINETICS, AND METABOLISM - IMPLICATIONS FOR THEIR LONG-TERM USE

      Journal of pharmacokinetics and biopharmaceutics
    59. BENET LZ; ROWLAND M
      UNTITLED

      Journal of pharmacokinetics and biopharmaceutics
    60. YUAN R; SUMI M; BENET LZ
      INVESTIGATION OF AORTIC CYP3A BIOACTIVATION OF NITROGLYCERIN IN-VIVO

      The Journal of pharmacology and experimental therapeutics
    61. LOWN KS; MAYO RR; LEICHTMAN AB; HSIAO HL; TURGEON DK; SCHMIEDLINREN P; BROWN MB; GUO WS; ROSSI SJ; BENET LZ; WATKINS PB
      ROLE OF INTESTINAL P-GLYCOPROTEIN (MDR1) IN INTERPATIENT VARIATION INTHE ORAL BIOAVAILABILITY OF CYCLOSPORINE

      Clinical pharmacology and therapeutics
    62. FLOREN LC; BEKERSKY I; BENET LZ; MEKKI Q; DRESSLER D; LEE JW; ROBERTS JP; HEBERT MF
      TACROLIMUS ORAL BIOAVAILABILITY DOUBLES WITH COADMINISTRATION OF KETOCONAZOLE

      Clinical pharmacology and therapeutics
    63. SHAH VP; YACOBI A; BARR WH; BENET LZ; BREIMER D; DOBRINSKA MR; ENDRENYI L; FAIRWEATHER W; GILLESPIE W; GONZALEZ MA; HOOPER J; JACKSON A; LESKO LJ; MIDHA KK; NOONAN PK; PATNAIK R; WILLIAMS RL
      EVALUATION OF ORALLY-ADMINISTERED HIGHLY VARIABLE DRUGS AND DRUG FORMULATIONS

      Pharmaceutical research
    64. SAMBOL NC; BROOKES LG; CHIANG J; GOODMAN AM; LIN ET; LIU CY; BENET LZ
      FOOD-INTAKE AND DOSAGE LEVEL, BUT NOT TABLET VS SOLUTION DOSAGE FORM,AFFECT THE ABSORPTION OF METFORMIN HCL IN MAN

      British journal of clinical pharmacology
    65. WACHER VJ; SALPHATI L; BENET LZ
      ACTIVE SECRETION AND ENTEROCYTIC DRUG-METABOLISM BARRIERS TO DRUG ABSORPTION

      Advanced drug delivery reviews
    66. BENET LZ; WU CY; HEBERT MF; WACHER VJ
      INTESTINAL DRUG-METABOLISM AND ANTITRANSPORT PROCESSES - A POTENTIAL PARADIGM SHIFT IN ORAL-DRUG DELIVERY

      Journal of controlled release
    67. SAMBOL NC; CHIANG J; OCONNER M; LIU CY; LIN ET; GOODMAN AM; BENET LZ; KARAM JH
      PHARMACOKINETICS AND PHARMACODYNAMICS OF METFORMIN IN HEALTHY-SUBJECTS AND PATIENTS WITH NONINSULIN-DEPENDENT DIABETES-MELLITUS

      Journal of clinical pharmacology
    68. IWAKI M; OGISO T; HAYASHI H; TANINO T; BENET LZ
      ACUTE DOSE-DEPENDENT DISPOSITION STUDIES OF NICOTINIC-ACID IN RATS

      Drug metabolism and disposition
    69. BERGCANDOLFI M; CANDOLFI E; BENET LZ
      SUPPRESSION OF INTESTINAL AND HEPATIC CYTOCHROME P4503A IN MURINE TOXOPLASMA INFECTION - EFFECTS OF N-ACETYLCYSTEINE AND N-G-MONOMETHYL-L-ARGININE ON THE HEPATIC SUPPRESSION

      Xenobiotica
    70. JAEGER W; BENET LZ; BORNHEIM LM
      INHIBITION OF CYCLOSPORINE AND TETRAHYDROCANNABINOL METABOLISM BY CANNABIDIOL IN MOUSE AND HUMAN MICROSOMES

      Xenobiotica
    71. BENET LZ
      MORALITY-PLAY

      Science
    72. HAJYEHIA AI; BENET LZ
      IN-VIVO DEPLETION OF FREE THIOLS DOES NOT ACCOUNT FOR NITROGLYCERIN-INDUCED TOLERANCE - A THIOL-NITRATE INTERACTION HYPOTHESIS AS AN ALTERNATIVE EXPLANATION FOR NITROGLYCERIN ACTIVITY AND TOLERANCE

      The Journal of pharmacology and experimental therapeutics
    73. HARRIS RZ; TSUNODA SM; MROCZKOWSKI P; WONG H; BENET LZ
      THE EFFECTS OF MENOPAUSE AND HORMONE REPLACEMENT THERAPIES ON PREDNISOLONE AND ERYTHROMYCIN PHARMACOKINETICS

      Clinical pharmacology and therapeutics
    74. CHANG T; BENET LZ; HEBERT MF
      THE EFFECT OF WATER-SOLUBLE VITAMIN-E ON CYCLOSPORINE PHARMACOKINETICS IN HEALTHY-VOLUNTEERS

      Clinical pharmacology and therapeutics
    75. JANG GR; WRIGHTON SA; BENET LZ
      IDENTIFICATION OF CYP3A4 AS THE PRINCIPAL ENZYME CATALYZING MIFEPRISTONE (RU-486) OXIDATION IN HUMAN LIVER-MICROSOMES

      Biochemical pharmacology
    76. KENKARE SR; BENET LZ
      TOLERANCE TO NITROGLYCERIN IN RABBIT AORTA - INVESTIGATING THE INVOLVEMENT OF THE MU-ISOZYME OF GLUTATHIONE S-TRANSFERASES

      Biochemical pharmacology
    77. HAJYEHIA AI; BENET LZ
      DETERMINATION OF ALCOHOLS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUOROMETRIC DETECTION AFTER PRECOLUMN DERIVATIZATION WITH 2-(4-CARBOXYPHENYL)-6-METHOXYBENZOFURAN

      Journal of chromatography
    78. HAJYEHIA AI; BENET LZ
      2-(4-N-MALEIMIDOPHENYL)-6-METHOXYBENZOFURAN - A SUPERIOR DERIVATIZINGAGENT FOR FLUOROMETRIC-DETERMINATION OF ALIPHATIC THIOLS BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

      Journal of chromatography B. Biomedical applications
    79. ZIAAMIRHOSSEINI P; HARRIS RZ; BRODSKY FM; BENET LZ
      HYPERSENSITIVITY TO NONSTEROIDAL ANTIINFLAMMATORY DRUGS

      Nature medicine
    80. SEKIKAWA H; YAGI N; ODA K; KENMOTSU H; TAKADA M; CHEN HF; LIN ET; BENET LZ
      BILIARY-EXCRETION OF FUROSEMIDE GLUCURONIDE IN RABBITS

      Biological & pharmaceutical bulletin
    81. SEKIKAWA H; YAGI N; LIN ET; BENET LZ
      APPARENT INTRAMOLECULAR ACYL MIGRATION AND HYDROLYSIS OF FUROSEMIDE GLUCURONIDE IN AQUEOUS-SOLUTION

      Biological & pharmaceutical bulletin
    82. WACHER VJ; WU CY; BENET LZ
      OVERLAPPING SUBSTRATE SPECIFICITIES AND TISSUE DISTRIBUTION OF CYTOCHROME-P450 3A AND P-GLYCOPROTEIN - IMPLICATIONS FOR DRUG-DELIVERY AND ACTIVITY IN CANCER-CHEMOTHERAPY

      Molecular carcinogenesis
    83. HAJYEHIA AI; BENET LZ
      DETERMINATION OF ALIPHATIC THIOLS BY FLUOROMETRIC HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AFTER PRECOLUMN DERIVATIZATION WITH 2-(4-N-MALEIMIDOPHENYL)-6-METHYLBENZOTHIAZOLE

      Pharmaceutical research
    84. BENET LZ; GOYAN JE
      BIOEQUIVALENCE AND NARROW THERAPEUTIC INDEX DRUGS

      Pharmacotherapy
    85. ZIAAMIRHOSSEINI P; DING A; BURLINGAME AL; MCDONAGH AF; BENET LZ
      SYNTHESIS AND MASS-SPECTROMETRIC CHARACTERIZATION OF HUMAN SERUM ALBUMINS MODIFIED BY COVALENT BINDING OF 2 NONSTEROIDAL ANTIINFLAMMATORY DRUGS - TOLMETIN AND ZOMEPIRAC

      Biochemical journal
    86. BENET LZ; ZIAAMIRHOSSEINI P
      BASIC PRINCIPLES OF PHARMACOKINETICS

      Toxicologic pathology
    87. WACHER VJ; LIU T; ROBERTS JP; ASCHER NL; BENET LZ
      TIME-COURSE OF CYCLOSPORINE AND ITS METABOLITES IN BLOOD, LIVER AND SPLEEN OF NAIVE LEWIS RATS - COMPARISON WITH PRELIMINARY DATA OBTAINED IN TRANSPLANTED ANIMALS

      Biopharmaceutics & drug disposition
    88. SAMBOL NC; CHIANG J; LIN ET; GOODMAN AM; LIU CY; BENET LZ; COGAN MG
      KIDNEY-FUNCTION AND AGE ARE BOTH PREDICTORS OF PHARMACOKINETICS OF METFORMIN

      Journal of clinical pharmacology
    89. DUSCIO CH; AWEEKA FT; PRUEKSARITANONT T; TOMLANOVICH SJ; GUPTA SK; LANTZ MV; GAMBERTOGLIO JG; GAROVOY MR; BENET LZ
      IMMUNOPHARMACODYNAMIC STUDIES OF CYCLOSPORINE IN PATIENTS AWAITING RENAL-TRANSPLANTATION

      Journal of clinical pharmacology
    90. BISCHER A; IWAKI M; ZIAAMIRHOSSEINI P; BENET LZ
      STEREOSELECTIVE REVERSIBLE BINDING-PROPERTIES OF THE GLUCURONIDE CONJUGATES OF FENOPROFEN ENANTIOMERS TO HUMAN SERUM-ALBUMIN

      Drug metabolism and disposition
    91. BORNHEIM LM; KIM KY; LI JM; PEROTTI BYT; BENET LZ
      EFFECT OF CANNABIDIOL PRETREATMENT ON THE KINETICS OF TETRAHYDROCANNABINOL METABOLITES IN MOUSE-BRAIN

      Drug metabolism and disposition
    92. DING A; ZIAAMIRHOSSEINI P; MCDONAGH AF; BURLINGAME AL; BENET LZ
      REACTIVITY OF TOLMETIN GLUCURONIDE WITH HUMAN SERUM-ALBUMIN - IDENTIFICATION OF BINDING-SITES AND MECHANISMS OF REACTION BY TANDEM MASS-SPECTROMETRY

      Drug metabolism and disposition
    93. IWAKI M; BISCHER A; NGUYEN AC; MCDONAGH AF; BENET LZ
      STEREOSELECTIVE DISPOSITION OF NAPROXEN GLUCURONIDE IN THE RAT

      Drug metabolism and disposition
    94. BISCHER A; ZIAAMIRHOSSEINI P; IWAKI M; MCDONAGH AF; BENET LZ
      STEREOSELECTIVE BINDING-PROPERTIES OF NAPROXEN GLUCURONIDE DIASTEREOMERS TO PROTEINS

      Journal of pharmacokinetics and biopharmaceutics
    95. HAJYEHIA AI; BENET LZ
      DISSOCIATION OF TISSUE THIOLS CONTENT FROM NITROGLYCERIN-INDUCED CYCLIC-3',5'-GUANOSINE MONOPHOSPHATE AND THE STATE OF TOLERANCE - IN-VIVO EXPERIMENTS IN RATS

      The Journal of pharmacology and experimental therapeutics
    96. HARRIS RZ; BENET LZ; SCHWARTZ JB
      GENDER EFFECTS IN PHARMACOKINETICS AND PHARMACODYNAMICS

      Drugs
    97. WU CY; BENET LZ; HEBERT MF; GUPTA SK; ROWLAND M; GOMEZ DY; WACHER VJ
      DIFFERENTIATION OF ABSORPTION AND FIRST-PASS GUT AND HEPATIC-METABOLISM IN HUMANS - STUDIES WITH CYCLOSPORINE

      Clinical pharmacology and therapeutics
    98. GOMEZ DY; WACHER VJ; TOMLANOVICH SJ; HEBERT MF; BENET LZ
      THE EFFECTS OF KETOCONAZOLE ON THE INTESTINAL METABOLISM AND BIOAVAILABILITY OF CYCLOSPORINE

      Clinical pharmacology and therapeutics
    99. CHANG T; BENET LZ; HEBERT MF
      THE EFFECT OF WATER-SOLUBLE VITAMIN-E (TPGS) ON ORAL CYCLOSPORINE PHARMACOKINETICS IN HEALTHY-VOLUNTEERS

      Clinical pharmacology and therapeutics
    100. TSUNODA SM; HARRIS RZ; MROCZKOWSKI PJ; HEBERT MF; BENET LZ
      ORAL PROGESTERONE THERAPY DOES NOT AFFECT THE PHARMACOKINETICS OF PREDNISOLONE AND ERYTHROMYCIN IN POSTMENOPAUSAL WOMEN

      Clinical pharmacology and therapeutics


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 15/08/20 alle ore 02:00:57